Вы прочитали книгу и уже большие молодцы! Я рекомендую вам прочитать ее два раза с интервалом в неделю и сделать конспект. Когда вы будете читать и конспектировать, то лучше поймете то, о чем идет речь. И самое главное, у вас появятся новые вопросы, ответы на которые вы сможете найти в других моих книгах.
И помните: практически все проблемы пищеварения можно и нужно решить!
Ваш доктор Вялов
Об авторе
Доктор Вялов Сергей Сергеевич
Overqualified гастроэнтеролог, гепатолог, к.м.н., MD, PhD
• 14 лет работы и 25000+ пациентов
• Опыт работы на западе: клиника Charite, Берлин, Испания и Чехия
• 160+ научных статей и 20+ книг для врачей
• 2850+ лекций для врачей РФ и СНГ
• Руководитель Гастро-центра клиники «Ланцет»
• Международное партнерство: AGA, UEGW, EASL – американская и европейская гастроэнтерология
• Первый врач с дополненной реальностью (AR augmented reality) в России
Эксперт федеральных телеканалов:
• О самом главном (Россия 1)
• Я худею (НТВ)
• Контрольная закупка (Первый)
Фильмы на Первом канале
• «Бактерии. Война миров» (2017)
• «Грипп. Вторжение» (2018)
• «Иммунитет. Токсины» (2021)
Доктор ведет открытый проект «Наболевшие вопросы», где все желающие получают ответы на свои вопросы бесплатно.
Официальный сайт
www.vyalov.com
Использованная литература
1. Thrift AP. Determination of risk for Barrett’s esophagus and esophageal adenocarcinoma. Curr Opin Gastroenterol. 2016
2. Zhao Z, Pu Z, Yin Z, et al. Dietary fruit, vegetable, fat, and red and processed meat intakes and Barrett’s esophagus risk: a systematic review and meta-analysis. Sci Rep. 2016
3. Iwakiri K, Kinoshita Y, Habu Y, et al. Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015. J Gastroenterol. 2016
4. Salvador R, Dubecz A, Polomsky M, et al. A new era in esophageal diagnostics: the image-based paradigm of high-resolution manometry. J Am Coll Surg. 2009
5. Martínek J, Akiyama JI, Vackova Z, et al. Current treatment options for esophageal diseases. Ann N Y Acad Sci. 2016
6. Vaezi MF. Review article: the role of pH monitoring in extraoesophageal gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2006
7. Hashmi S, Rao SS, Summers RW, Schulze K. Esophageal pressure topography, body position, and hiatal hernia. J Clin Gastroenterol. 2014
8. Malhotra A, Freston JW, Aziz K. Use of pH-impedance testing to evaluate patients with suspected extraesophageal manifestations of gastroesophageal reflux disease. J Clin Gastroenterol. 2008
9. Zalvan CH, Hu S, Greenberg B, Geliebter J. A Comparison of Alkaline Water and Mediterranean Diet vs Proton Pump Inhibition for Treatment of Laryngopharyngeal Reflux. JAMA Otolaryngol Head Neck Surg. 2017
10. Fass R, Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut. 2009
11. Kellerman R, Kintanar T. Gastroesophageal reflux disease. Prim Care. 2017
12. Ratcliffe EG, Jankowski JA. Gastroesophageal reflux disease and Barrett’s oesophagus: an overview of evidence-based guidelines. Pol Arch Intern Med. 2019
13. Rodriguez-Castro KI, Franceschi M, Miraglia C, et al. Autoimmune diseases in autoimmune atrophic gastritis. Acta Biomed. 2018
14. Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol. 2012
15. Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018
16. Zhang Y, Weck MN, Schottker B, et al. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: evidence from a large population-based study in Germany. Cancer Epidemiol Biomarkers Prev. 2013
17. Early DS, Lightdale JR, Vargo JJ 2nd, et al, for the ASGE Standards of Practice Committee. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018
18. Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017
19. Sipponen P, Maaroos HI. Chronic gastritis. Scand J Gastroenterol. 2015
20. Genta RM. Differential diagnosis of reactive gastropathy. Semin Diagn Pathol. 2005
21. Aldoori WH, Giovannucci EL, Stampfer MJ, Rimm EB, Wing AL, Willett WC. A prospective study of alcohol, smoking, caffeine, and the risk of duodenal ulcer in men. Epidemiology. 1997
22. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology. 2008
23. Lanas A, Chan FKL. Peptic ulcer disease. Lancet. 2017
24. Azhari H, Underwood F, King J, et al. The global incidence of peptic ulcer disease and its complications at the turn of the 21st century: a systematic review. J Can Assoc Gastroenterol. 2018
25. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010
26. Lanza FL, Chan FK, Quigley EM, for the Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol. 2009
27. Strand DS, Kim D, Peura DA. 25 years of proton pump inhibitors: a comprehensive review. Gut Liver. 2017
28. Huffman JL, Schenker S. Acute acalculous cholecystitis: a review. Clin Gastroenterol Hepatol. 2010
29. Donovan JM. Physical and metabolic factors in gallstone pathogenesis. Gastroenterol Clin North Am. 1999
30. Sitzmann JV, Pitt HA, Steinborn PA, et al. Cholecystokinin prevents parenteral nutrition induced biliary sludge in humans. Surg Gynecol Obstet. 1990
31. Rubens DJ. Hepatobiliary imaging and its pitfalls. Radiol Clin North Am. 2004
32. Knab LM, Boller AM, Mahvi DM. Cholecystitis. Surg Clin North Am. 2014
33. Sulzer JK, Ocuin LM. Cholangitis: causes, diagnosis, and management. Surg Clin North Am. 2019
34. Center SA. Diseases of the gallbladder and biliary tree. Vet Clin North Am Small Anim Pract. 2009
35. Wang HH, Liu M, Clegg DJ, Portincasa P, Wang DQ. New insights into the molecular mechanisms underlying effects of estrogen on cholesterol gallstone formation. Biochim Biophys Acta. 2009
36. Dauer M, Lammert F. Mandatory and optional function tests for biliary disorders. Best Pract Res Clin Gastroenterol. 2009
37. Behar J, Corazziari E, Guelrud M, Hogan W, Sherman S, Toouli J. Functional gallbladder and sphincter of oddi disorders. Gastroenterology. 2006
38. Littlefield A, Lenahan C. Cholelithiasis: presentation and management. J Midwifery Womens Health. 2019
39. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Clin Gastroenterol Hepatol. 2009
40. Redwan AA. Multidisciplinary approaches for management of postcholecystectomy problems (surgery, endoscopy, and percutaneous approaches). Surg Laparosc Endosc Percutan Tech. 2009
41. Banks PA. Epidemiology, natural history, and predictors of disease outcome in acute and chronic pancreatitis. Gastrointest Endosc. 2002
42. Pezzilli R. Etiology of chronic pancreatitis: has it changed in the last decade?. World J Gastroenterol. 2009
43. Kawa S, Hamano H, Ozaki Y, et al. Long-term follow-up of autoimmune pancreatitis: characteristics of chronic disease and recurrence. Clin Gastroenterol Hepatol. 2009
44. Tezuka K, Makino T, Hirai I, Kimura W. Groove pancreatitis. Dig Surg. 2010.
45. Dominguez-Munoz JE, Drewes AM, Lindkvist B, et al, for the HaPanEU/UEG Working Group. Recommendations from the United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis. Pancreatology. 2018
46. Owens SR, Greenson JK. The pathology of malabsorption: current concepts. Histopathology. 2007
1. Green PH, Lebwohl B, Greywoode R. Celiac disease. J Allergy Clin Immunol. 2015
2. Malik TF, Panuganti KK. Lactose intolerance. Stat Pearls. 2019
3. Alyami J, Spiller RC, Marciani L. Magnetic resonance imaging to evaluate gastrointestinal function. Neurogastroenterol Motil. 2015
4. Vanuytsel T, Tack JF, Boeckxstaens GE. Treatment of abdominal pain in irritable bowel syndrome. J Gastroenterol. 2014
5. Sarna SK. Molecular, functional, and pharmacological targets for the development of gut promotility drugs. Am J Physiol Gastrointest Liver Physiol. 2006
6. Di Stefano M, Miceli E, Mazzocchi S, et al. Visceral hypersensitivity and intolerance symptoms in lactose malabsorption. Neurogastroenterol Motil. 2007
7. Toorenvliet B, Vellekoop A, Bakker R, et al. Clinical differentiation between acute appendicitis and acute mesenteric lymphadenitis in children. Eur J Pediatr Surg. 2011
8. Husebye E. Gastrointestinal motility disorders and bacterial overgrowth. J Intern Med. 1995
9. Kastin DA, Buchman AL. Malnutrition and gastrointestinal disease. Curr Opin Gastroenterol. 2002
10. Saltzman JR, Russell RM. Nutritional consequences of intestinal bacterial overgrowth.